More about

Ovarian Cancer

News
November 16, 2022
2 min read
Save

FDA approves mirvetuximab soravtansine-gynx for subset of women with ovarian cancer

FDA approves mirvetuximab soravtansine-gynx for subset of women with ovarian cancer

The FDA granted accelerated approval to mirvetuximab soravtansine-gynx for treatment of certain adults with epithelial ovarian, fallopian tube or primary peritoneal cancer.

News
November 09, 2022
3 min read
Save

Black women less likely to receive guideline-concordant therapy for ovarian cancer

Black women less likely to receive guideline-concordant therapy for ovarian cancer

Black women in the U.S. appeared less likely than white women to receive guideline-concordant treatment for ovarian cancer, according to a study published in Journal of the National Comprehensive Cancer Network.

News
September 17, 2022
1 min read
Save

Ovarian Cancer Awareness Month: Studies show advances in treatment, symptom management

Ovarian Cancer Awareness Month: Studies show advances in treatment, symptom management

September is Ovarian Cancer Awareness Month.

News
September 09, 2022
3 min read
Save

Novel bispecific T-cell receptor therapy shows early promise in advanced solid tumors

Novel bispecific T-cell receptor therapy shows early promise in advanced solid tumors

An off-the-shelf T-cell receptor therapy has shown promising early results in multiple solid tumor types, according to initial data from a phase 1 dose-escalation trial presented at ESMO Congress.

News
September 09, 2022
3 min read
Save

Olaparib regimen extends survival for certain women with advanced ovarian cancer

Olaparib regimen extends survival for certain women with advanced ovarian cancer

Maintenance therapy with olaparib and bevacizumab extended survival for women with newly diagnosed advanced ovarian cancer with homologous recombination deficiency, according to study results.

News
August 26, 2022
2 min read
Save

Genetic counseling relatively low cost, ‘should be offered to more at-risk patients’

Genetic counseling relatively low cost, ‘should be offered to more at-risk patients’

Submitted medical claims and out-of-pocket costs for genetic counseling encounters appeared relatively low among patients with certain cancer types, according to a research letter published in JAMA Health Forum.

News
August 11, 2022
2 min read
Save

Daily aspirin use may reduce ovarian cancer risk among high-risk patients

Daily aspirin use may reduce ovarian cancer risk among high-risk patients

Women who take aspirin frequently may reduce their risk for ovarian cancer, according to results of a meta-analysis published in Journal of Clinical Oncology.

News
July 20, 2022
1 min read
Save

Gene therapy fails to significantly extend survival in ovarian cancer, topline data show

Gene therapy fails to significantly extend survival in ovarian cancer, topline data show

A phase 3 trial of ofranergene obadenovec in platinum-resistant ovarian cancer failed to meet its primary endpoints of statistically significant improvement in PFS and OS, according to topline data released by the agent’s manufacturer.

News
June 28, 2022
10 min read
Save

Novel approaches highlight potential of cell therapy for a wider array of cancers

Novel approaches highlight potential of cell therapy for a wider array of cancers

The ideal strategy to treat cancer with cell therapy can vary greatly depending on tumor type.

News
June 18, 2022
4 min read
Save

Tool improves women’s ‘sense of control’ over ovarian cancer symptoms

Tool improves women’s ‘sense of control’ over ovarian cancer symptoms

Women with recurrent ovarian cancer experience an average of 14 disease or treatment-related symptoms at any given time over the course of their disease.

View more